Share Based Compensation (Tables)

9 Months Ended

Sep. 30, 2018

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The assumptions used to value SARs granted during 2017 were as follows:

	5-year vesting SARs		7-year vesting SARs
Risk-free interest rate	2.16	%	2.24	%
Expected dividend yield	1.45	%	1.45	%
Expected common stock volatility	60.05	%	59.60	%
Expected life	6.5 years		7.0 years

Schedule of Share-based Compensation, Stock Options, Activity

A summary of activity in our Plans during the first nine months of 2018 and 2017 is as follows:

	For the Nine Months Ended September 30,
	2018
	Options/SARs		Aggregate Intrinsic Value		Remaining Contractual Term (Yrs.)	Weighted-Average Exercise Price
Outstanding, January 1	250,291					$	17.75
Granted	—					—
Exercised	(1,600	)				17.79
Forfeited	(3,200	)				25.50
Expired	—					—
Outstanding, September 30	245,491		$	1,645	6.62	$	17.65
Exercisable, September 30	109,324		$	898	5.55	$	15.77

	For the Nine Months Ended September 30,
	2017
	Options/SARs		Aggregate Intrinsic Value		Remaining Contractual Term (Yrs.)	Weighted-Average Exercise Price
Outstanding, January 1	217,857					$	13.56
Granted	87,615					26.01
Exercised	(2,000	)				6.21
Forfeited	—					—
Expired	—					—
Outstanding, September 30	303,472		$	2,604	7.11	$	17.20
Exercisable, September 30	115,827		$	1,239	5.01	$	15.02